Clinical Trial Update: Protein Biomarker in Hepatocellular Carcinoma

View source ↗

Summary

This clinical trial update reports termination of a study evaluating a protein biomarker in hepatocellular carcinoma, sponsored by the Johns Hopkins Sidney Kimm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Cirrhosis
• Viral Hepatitis

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Normal Volunteers, Hepatitis | Status: TERMINATED